Periodontal Status and Disease Severity in Hidradenitis Suppurativa Patients

NCT ID: NCT07294456

Last Updated: 2025-12-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

226 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-01

Study Completion Date

2025-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This cross-sectional study aims to evaluate the periodontal status of individuals diagnosed with hidradenitis suppurativa (HS) and to compare them with systemically healthy controls. HS is a chronic inflammatory skin disease characterized by recurrent lesions and systemic inflammation, which may influence periodontal health. In this study, periodontal parameters-including probing depth, clinical attachment loss, gingival index, plaque index, and bleeding on probing-will be assessed using standard clinical methods. Dermatological examination will include disease duration, lesion characteristics, and Hurley staging. The study will investigate the prevalence of periodontitis in HS patients and explore potential associations between periodontal findings and HS severity. Findings from this research may provide insight into shared inflammatory pathways and contribute to understanding the possible link between HS and periodontal disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HİDRADENİTİS SUPPURATİVA

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

HİDRADENİTİS SUPPURATİVA PERİODONTAL DİSEASE PERİODONTİTİS GİNGİVAL İNFLAMMATİON

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hidradenitis Suppurativa Group

Participants diagnosed with hidradenitis suppurativa undergoing periodontal examination.

No intervention (observational study)

Intervention Type OTHER

Observational study with no treatment or intervention applied.

Healthy Control Group

Systemically healthy individuals without hidradenitis suppurativa undergoing periodontal examination.

No intervention (observational study)

Intervention Type OTHER

Observational study with no treatment or intervention applied.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention (observational study)

Observational study with no treatment or intervention applied.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having a diagnosis of hidradenitis suppurativa.
* Age greater than 18 years.
* Presence of at least 12 teeth in the mouth, excluding third molars.

Exclusion Criteria

* Age under 18 years.
* Pregnancy.
* Breastfeeding.
* Receiving treatment for periodontitis or hidradenitis suppurativa within the past 3 months.
* Use of antibiotics, anti-inflammatory drugs, or immunomodulatory medications within the past 3 months.
Minimum Eligible Age

18 Minutes

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saglik Bilimleri Universitesi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Şeyma Çardakçı

ASSİSTANT PROFESSOR

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Health Sciences, Gülhane Faculty of Dentistry

Ankara, None Selected, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SUDE1824

Identifier Type: -

Identifier Source: org_study_id